Statistics for Milestone Pharmaceuticals Inc (id:8305 MIST)

Valuation metrics

Market cap

90.66M

Enterprise value

93.76M

Trailing P/E (ttm)

-1.32

Forward P/E

-1.98

PEG ratio

-1.98

Price/Sales (ttm)

90.66

Price/Book (mrq)

4.37

Enterprise Value/Revenue

93.76

Enterprise Value/EBITDA

-1.91

Overview

Shares outstanding

53.27M

Float

52.79M

Shares short

454.79K

% Held by insiders

0.01%

% Held by institutions

0.57%

Average volume (10 days)

723.87K

Average volume (90 days)

Price summary

52-Week low

1.12

52-Week high

3.52

52-Week change

-52.72%

Beta

1.73

50-Day moving average

1.55

200-Day moving average

1.55

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-5,713.10%

Operational effectiveness

Return on assets

-33.09%

Return on equity

-133.75%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-49,194,000.00

Net income to common (ttm)

-48,409,000.00

Diluted EPS (ttm)

-1.01

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

83.25M

Total cash per share (mrq)

1.26

Total debt (mrq)

53.25M

Total Debt/Equity (mrq)

166.53

Current ratio (mrq)

1.91K%

Book value per share (mrq)

0.39

Cash flow

Cash flow statement

-36,943,000.00

Levered free cash flow (LFCF)

-23,841,876.00